OR WAIT null SECS
© 2022 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
iCardiac announced that it has been selected to work on an early phase oncology clinical trial with a global Japanese pharma company.
iCardiac announced that it has been selected to work on an early phase oncology clinical trial with a global Japanese pharma company. This study will utilize iCardiac’s Rapid QT service offering, which assists trial sites in making accurate patient inclusion/exclusion decisions.
Read the full release here